All In Biotech

Drug Trial Radar · NCT04479852

A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder

Last checked: Nov 19, 2026Latest source record: Jun 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 319 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

319

Actual

Start

Sep 30, 2020

Primary completion

Jun 27, 2022

Study completion Aug 9, 2022

Sponsor

Lead sponsor
Sirtsei Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Jul 21, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2 clinical study evaluating the safety and effectiveness of SP-624 as compared to placebo in the treatment of adults with Major Depressive Disorder.

Conditions

  • Major Depressive Disorder

Interventions

  • SP-624Drug

    Oral capsule

  • PlaceboDrug

    Oral capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Week 4 in Montgomery Asberg Depression Rating Scale (MADRS) Total ScoreTime frame: Baseline to Week 4

Locations

39 sites in 1 country. Site status is shown where the registry gives one.

  • Alea Research

    Phoenix, Arizona

  • Woodland International Research Group

    Little Rock, Arkansas

  • Woodland Research Northwest

    Rogers, Arkansas

  • Collaborative Neuroscience Research

    Garden Grove, California

  • Pacific Research Partners

    Oakland, California

  • Artemis Institute for Clinical Research

    San Diego, California

  • Collaborative Neuroscience Research

    Torrance, California

  • MCB Clinical Research Centers

    Colorado Springs, Colorado

  • Sarkis Clinical Trials

    Gainesville, Florida

  • Clinical Neuroscience Solutions, Inc.

    Jacksonville, Florida

  • Innovative Clinical Research

    Lauderhill, Florida

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida

  • Institute for Advanced Medical Research

    Alpharetta, Georgia

  • Atlanta Center for Medical Research

    Atlanta, Georgia

  • iResearch Atlanta

    Decatur, Georgia

  • American Medical Research

    Chicago, Illinois

  • Capstone Clinical Research

    Libertyville, Illinois

  • CBH Health

    Gaithersburg, Maryland

  • Midwest Research Group

    Saint Charles, Missouri

  • Altea Research Institute

    Las Vegas, Nevada

  • Hassman Research Institute

    Berlin, New Jersey

  • Center for Emotional Fitness

    Cherry Hill, New Jersey

  • Hassman Research Institute

    Marlton, New Jersey

  • SPRI Clinical Trials

    Brooklyn, New York

  • Manhattan Behavioral Medicine

    New York, New York

  • Richmond Behavioral Associates

    Staten Island, New York

  • New Hope Clinical Research

    Charlotte, North Carolina

  • Clinical Trials of America

    Hickory, North Carolina

  • Midwest Clinical Research Center

    Dayton, Ohio

  • Cutting Edge Research Group

    Oklahoma City, Oklahoma

  • Oregon Center for Clinical Investigations

    Portland, Oregon

  • Oregon Center for Clinical Investigations

    Salem, Oregon

  • Lehigh Center for Clinical Research

    Allentown, Pennsylvania

  • Clinical Neuroscience Solutions, Inc.

    Memphis, Tennessee

  • Donald J. Garcia, Jr., MD, PA

    Austin, Texas

  • Future Search Trials of Dallas

    Dallas, Texas

  • Red Oak Psychiatry Associates

    Houston, Texas

  • Grayline Research Center

    Wichita Falls, Texas

  • Core Clinical Research

    Everett, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.